Crystal Rock Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.64M Hold
3,865
2.36% 18
2026
Q1
$3.55M Sell
3,865
-160
-4% -$162K 2.11% 17
2025
Q4
$4.33M Hold
4,025
2.29% 17
2025
Q3
$3.07M Buy
4,025
+850
+27% +$633K 1.68% 21
2025
Q2
$2.48M Buy
3,175
+935
+42% +$727K 1.43% 23
2025
Q1
$1.85M Buy
+2,240
New +$1.86M 1.27% 23

Other funds holding LLY

Crystal Rock Capital Management's LLY Position: Q2 2026 in Review

Crystal Rock Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 3,865 shares worth $4.64M. The position accounts for 2.36% of the portfolio, ranked #18.

Crystal Rock Capital Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Crystal Rock Capital Management held 3,865 shares of Eli Lilly worth $4.64M as of Q2 2026.
  • Crystal Rock Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 2.36% of Crystal Rock Capital Management's portfolio in Q2 2026, its #18 holding.
  • Crystal Rock Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Crystal Rock Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.